Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
$103.7m
reported value
-22.3% vs Q1 2024
13positions
92.7%in top 10
3 new
2 added
6 reduced
0 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $23.6m22.76% | Unchanged |
| BLUEPRINT MEDICINES CORP BPMC | $12.4m11.91% | Reduced -67.6k |
| ARVINAS INC ARVN | $11.4m11.00% | Added +23.0k |
| REGENXBIO INC RGNX | $10.6m10.22% | Unchanged |
| KYMERA THERAPEUTICS INC KYMR | $9.8m9.46% | Reduced -60.0k |
| SILENCE THERAPEUTICS PLC SLN | $9.5m9.16% | Reduced -74.0k |
| MERUS N V MRUS | $8.8m8.45% | Reduced -107.0k |
| PRECISION BIOSCIENCES INC DTIL | $3.7m3.58% | Reduced -3.6k |
| BICYCLE THERAPEUTICS PLC BCYC | $3.2m3.06% | New |
| REPARE THERAPEUTICS INC RPTX | $3.2m3.04% | Added +323.7k |
| ADICET BIO INC COM | $3.1m2.95% | New |
| IMMATICS N.V IMTX | $2.3m2.24% | New |
| SUTRO BIOPHARMA INC COM | $2.2m2.15% | Reduced -403.0k |